{"id":"https://openalex.org/W7212075929","doi":"https://doi.org/10.1016/j.medj.2026.101293","title":"Pomalidomide plus bortezomib and dexamethasone for newly diagnosed multiple myeloma with renal impairment: Randomized phase II study (POM-MM-003)","display_name":"Pomalidomide plus bortezomib and dexamethasone for newly diagnosed multiple myeloma with renal impairment: Randomized phase II study (POM-MM-003)","publication_year":2026,"publication_date":"2026-09-09","ids":{"openalex":"https://openalex.org/W7212075929","doi":"https://doi.org/10.1016/j.medj.2026.101293","pmid":"https://pubmed.ncbi.nlm.nih.gov/42716009"},"language":"en","primary_location":{"id":"doi:10.1016/j.medj.2026.101293","doi":"https://doi.org/10.1016/j.medj.2026.101293","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.medj.2026.101293","pdf_url":null,"source":{"id":"https://openalex.org/S4210167770","display_name":"Med","issn_l":"2666-6340","issn":["2666-6340","2666-6359"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.medj.2026.101293","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5150873845","display_name":"Fei Xiao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2800570007","display_name":"Renji Hospital","ror":"https://ror.org/03ypbx660","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800570007"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fei Xiao","raw_affiliation_strings":["Department of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2800570007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085995024","display_name":"Liru Wang","orcid":"https://orcid.org/0009-0007-3465-3279","observed_orcids":["https://orcid.org/0009-0007-3465-3279"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liru Wang","raw_affiliation_strings":["Department of Hematology, Fu Xing Hospital, Capital Medical University, Beijing 100038, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Fu Xing Hospital, Capital Medical University, Beijing 100038, China","institution_ids":["https://openalex.org/I183519381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100325900","display_name":"Fei Li","orcid":"https://orcid.org/0000-0001-6259-8990","observed_orcids":["https://orcid.org/0000-0001-6259-8990","https://orcid.org/0000-0003-3923-4114"]},"institutions":[{"id":"https://openalex.org/I4210164024","display_name":"First Affiliated Hospital of Nanchang University","ror":"https://ror.org/05gbwr869","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210164024"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fei Li","raw_affiliation_strings":["Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang 330000, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang 330000, China","institution_ids":["https://openalex.org/I4210164024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151018461","display_name":"Fang Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fang Wang","raw_affiliation_strings":["Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064148340","display_name":"Yuping Zhong","orcid":"https://orcid.org/0000-0001-6277-1183","observed_orcids":["https://orcid.org/0000-0001-6277-1183"]},"institutions":[{"id":"https://openalex.org/I4210119987","display_name":"Qingdao Municipal Hospital","ror":"https://ror.org/02jqapy19","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210119987"]},{"id":"https://openalex.org/I4405280210","display_name":"University of Health and Rehabilitation Sciences","ror":"https://ror.org/02kjtx631","country_code":"CN","type":"education","lineage":["https://openalex.org/I4405280210"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuping Zhong","raw_affiliation_strings":["Department of Hematology, Qingdao Hospital, University of Health and Rehabilitation Science, Qingdao Municipal Hospital, Qingdao 266071, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Qingdao Hospital, University of Health and Rehabilitation Science, Qingdao Municipal Hospital, Qingdao 266071, China","institution_ids":["https://openalex.org/I4210119987","https://openalex.org/I4405280210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101021241","display_name":"Xiaoyan Qu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152119","display_name":"Jiangsu Province Hospital","ror":"https://ror.org/04py1g812","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210152119"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoyan Qu","raw_affiliation_strings":["Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China","institution_ids":["https://openalex.org/I4210152119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123892681","display_name":"Chunkang Chang","orcid":"https://orcid.org/0000-0001-5318-5879","observed_orcids":["https://orcid.org/0000-0001-5318-5879"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I4210144482","display_name":"Shanghai Sixth People's Hospital","ror":"https://ror.org/049zrh188","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210144482"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chunkang Chang","raw_affiliation_strings":["Department of Hematology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200233, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200233, China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210144482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100330758","display_name":"Zhenyu Li","orcid":"https://orcid.org/0000-0003-4610-9135","observed_orcids":["https://orcid.org/0000-0003-4610-9135"]},"institutions":[{"id":"https://openalex.org/I4210106614","display_name":"Affiliated Hospital of Xuzhou Medical College","ror":"https://ror.org/011xhcs96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhenyu Li","raw_affiliation_strings":["Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China","institution_ids":["https://openalex.org/I4210106614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100355812","display_name":"Yang Liu","orcid":"https://orcid.org/0000-0002-1871-6889","observed_orcids":["https://orcid.org/0000-0002-1871-6889"]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Liu","raw_affiliation_strings":["Department of Hematology, Peking University People's Hospital, Beijing 100044, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Peking University People's Hospital, Beijing 100044, China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109628949","display_name":"Xuelin Dou","orcid":"https://orcid.org/0000-0001-7040-9272","observed_orcids":["https://orcid.org/0000-0001-7040-9272"]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xuelin Dou","raw_affiliation_strings":["Department of Hematology, Peking University People's Hospital, Beijing 100044, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Peking University People's Hospital, Beijing 100044, China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143455759","display_name":"Wen Lei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lei Wen","raw_affiliation_strings":["Department of Hematology, Peking University People's Hospital, Beijing 100044, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Peking University People's Hospital, Beijing 100044, China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138371800","display_name":"Nan Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Nan Peng","raw_affiliation_strings":["Department of Hematology, Peking University People's Hospital, Beijing 100044, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Peking University People's Hospital, Beijing 100044, China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032417098","display_name":"Jin Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jin Lu","raw_affiliation_strings":["Department of Hematology, Peking University People's Hospital, Beijing 100044, China. Electronic address: lujin@pku.edu.cn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Peking University People's Hospital, Beijing 100044, China. Electronic address: lujin@pku.edu.cn","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5151063026","display_name":"Jian Hou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2800570007","display_name":"Renji Hospital","ror":"https://ror.org/03ypbx660","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800570007"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jian Hou","raw_affiliation_strings":["Department of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China. Electronic address: 721006652@shsmu.edu.cn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China. Electronic address: 721006652@shsmu.edu.cn","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2800570007"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5032417098","https://openalex.org/A5151063026"],"corresponding_institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2800570007","https://openalex.org/I4210124809"],"apc_list":{"value":9350,"currency":"USD","value_usd":9350},"apc_paid":{"value":9350,"currency":"USD","value_usd":9350},"fwci":3.8809,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.86583757,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"7","issue":"10","first_page":"101293","last_page":"101293"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8420000076293945},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9589999914169312},{"id":"https://openalex.org/keywords/pomalidomide","display_name":"pomalidomide","score":0.8420000076293945},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":1.0},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.7639999985694885},{"id":"https://openalex.org/keywords/very-good-partial-response","display_name":"very good partial response","score":0.9739999771118164},{"id":"https://openalex.org/keywords/renal-response","display_name":"renal response","score":0.6470000147819519},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9269999861717224},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8289999961853027},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.9739999771118164},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.5040000081062317},{"id":"https://openalex.org/keywords/deintensification","display_name":"treatment deintensification","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.9056000113487244},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.84579998254776},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7778000235557556},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7242000102996826},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.6661999821662903},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6115000247955322},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4788999855518341},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.37860000133514404},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3598000109195709},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29269999265670776},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.26440000534057617},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.2637999951839447},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.26260000467300415}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.medj.2026.101293","doi":"https://doi.org/10.1016/j.medj.2026.101293","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.medj.2026.101293","pdf_url":null,"source":{"id":"https://openalex.org/S4210167770","display_name":"Med","issn_l":"2666-6340","issn":["2666-6340","2666-6359"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med","raw_type":"journal-article"},{"id":"pmid:42716009","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42716009","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.medj.2026.101293","doi":"https://doi.org/10.1016/j.medj.2026.101293","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.medj.2026.101293","pdf_url":null,"source":{"id":"https://openalex.org/S4210167770","display_name":"Med","issn_l":"2666-6340","issn":["2666-6340","2666-6359"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G3973263404","display_name":null,"funder_award_id":"82370203","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G6191464596","display_name":null,"funder_award_id":"7264339","funder_id":"https://openalex.org/F4320322919","funder_display_name":"Natural Science Foundation of Beijing Municipality"},{"id":"https://openalex.org/G6261844436","display_name":null,"funder_award_id":"RDJP2025-06","funder_id":"https://openalex.org/F4320324787","funder_display_name":"Peking University"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320322919","display_name":"Natural Science Foundation of Beijing Municipality","ror":null},{"id":"https://openalex.org/F4320324787","display_name":"Peking University","ror":"https://ror.org/02v51f717"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1973999018","https://openalex.org/W1983533694","https://openalex.org/W1988998251","https://openalex.org/W2004903490","https://openalex.org/W2035155995","https://openalex.org/W2039196526","https://openalex.org/W2066700805","https://openalex.org/W2125477622","https://openalex.org/W2129126701","https://openalex.org/W2140017817","https://openalex.org/W2147731532","https://openalex.org/W2287899290","https://openalex.org/W2299833483","https://openalex.org/W2319804562","https://openalex.org/W2486629951","https://openalex.org/W2945852816","https://openalex.org/W2972305086","https://openalex.org/W3036094758","https://openalex.org/W3081709649","https://openalex.org/W3082053425","https://openalex.org/W3091008757","https://openalex.org/W3118681630","https://openalex.org/W3136388199","https://openalex.org/W3197669971","https://openalex.org/W4200312283","https://openalex.org/W4226007718","https://openalex.org/W4285116674","https://openalex.org/W4360860120","https://openalex.org/W4366589824","https://openalex.org/W4382930345","https://openalex.org/W4387082232","https://openalex.org/W4388282597","https://openalex.org/W4389218841","https://openalex.org/W4400094382","https://openalex.org/W4408426971","https://openalex.org/W4412070200"],"related_works":["https://openalex.org/W4283396773","https://openalex.org/W3215387642","https://openalex.org/W4417002252","https://openalex.org/W4389220312","https://openalex.org/W7213955593","https://openalex.org/W2980918017","https://openalex.org/W4310167587","https://openalex.org/W4417002335","https://openalex.org/W4310163667","https://openalex.org/W4405042077"],"abstract_inverted_index":{"BACKGROUND:":[0],"POM-MM-003":[1,18],"study":[2,24],"compared":[3],"pomalidomide-bortezomib-dexamethasone":[4],"(PVd)":[5],"with":[6,15,34,37,180,185],"Vd":[7,51,100,150],"in":[8,29,110,162,175,190],"newly":[9],"diagnosed":[10],"multiple":[11],"myeloma":[12],"(NDMM)":[13],"patients":[14,91,179],"RI.":[16],"METHODS:":[17],"was":[19,70,213,225],"open-label,":[20],"randomized,":[21],"phase":[22],"II":[23],"done":[25],"at":[26],"eight":[27],"centers":[28],"China":[30,234],"(ClinicalTrials.gov:":[31],"NCT05432414).":[32],"Patients":[33],"symptomatic":[35],"NDMM":[36],"RI":[38],"(creatinine":[39],"clearance":[40],"\u226515":[41],"to":[42,48,94],"<60":[43],"mL/min)":[44],"were":[45,92,165],"randomly":[46],"2:1":[47],"PVd":[49,95,108,181,192,199],"and":[50,86,99,131,158,182,224,244],"groups":[52,164],"for":[53,206],"two":[54],"21-day":[55],"induction":[56],"cycles,":[57],"followed":[58],"by":[59,215,227],"additional":[60],"2-cycle":[61],"same":[62],"treatment":[63,204],"when":[64],"achieving":[65],"minor":[66],"response.":[67],"Primary":[68],"endpoint":[69],"very":[71],"good":[72],"partial":[73],"response":[74,133],"or":[75],"better":[76],"(\u2265VGPR)":[77],"after":[78,151],"4-cycle":[79,106,152],"induction.":[80,153],"FINDINGS:":[81],"Between":[82],"January":[83],"18,":[84],"2023":[85],"December":[87],"2,":[88],"2024,":[89],"82":[90],"randomized":[93],"(n":[96,101],"=":[97,102,147],"58)":[98],"24)":[103],"groups.":[104],"After":[105],"induction,":[107],"resulted":[109],"a":[111,202],"significantly":[112],"higher":[113],"\u2265":[114],"VGPR":[115],"rate":[116,134],"(72.4%":[117],"[42/58;":[118],"95%":[119,125,137,143],"CI:":[120,126,138,144],"59.1-83.3]":[121],"vs.":[122,140],"20.8%":[123],"[5/24;":[124],"7.1-42.2];":[127],"p":[128,146],"<":[129],"0.001)":[130],"renal":[132],"(75.9%":[135],"[44/58;":[136],"62.8-86.1]":[139],"45.8%":[141],"[11/24;":[142],"25.6-67.2];":[145],"0.009)":[148],"versus":[149],"Median":[154],"progression-free":[155],"survival":[156,160],"(PFS)":[157],"overall":[159],"(OS)":[161],"both":[163],"not":[166],"reached.":[167],"Grade":[168],"3-4":[169],"treatment-related":[170,196],"adverse":[171],"events":[172],"(TRAEs)":[173],"occurred":[174],"41.4%":[176],"(24/58)":[177],"of":[178,195,233],"29.2%":[183],"(7/24)":[184],"Vd.":[186],"Only":[187],"one":[188],"case":[189],"the":[191,228,237,245],"group":[193],"died":[194],"ileus.":[197],"CONCLUSIONS:":[198],"may":[200],"represent":[201],"potential":[203],"option":[205],"this":[207],"patient":[208],"population.":[209],"FUNDING:":[210],"This":[211],"trial":[212],"sponsored":[214],"Chia":[216],"Tai":[217],"Tianqing":[218],"Pharmaceutical":[219],"Group":[220],"Co.,":[221],"Ltd.":[222],"(2021072900001)":[223],"funded":[226],"National":[229],"Natural":[230,239],"Science":[231,240],"Foundation":[232,241],"(no.":[235,242],"82370203),":[236],"Beijing":[238],"7264339),":[243],"Peking":[246],"University":[247],"People's":[248],"Hospital":[249],"Scientific":[250],"Research":[251],"Development":[252],"Funds":[253],"(RDJP2025-06).":[254]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-09-10T00:00:00"}